Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.
about
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer.Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.Drug discovery from natural sources.Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.Risk factors for predicting severe neutropenia induced by amrubicin in patients with advanced lung cancer.
P2860
Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@ast
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@en
type
label
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@ast
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@en
prefLabel
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@ast
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@en
P2093
P2860
P1476
Phase I/II study of amrubicin, ...... ed non-small-cell lung cancer.
@en
P2093
Harumichi Ikegami
Masahiro Fukuoka
Minoru Takada
Shinichiro Nakamura
Shunichi Negoro
Takahiko Sugiura
Takashi Yana
Yutaka Ariyoshi
P2860
P2888
P304
P356
10.1007/S10637-005-1441-3
P577
2005-08-01T00:00:00Z
P6179
1027127248